Beatriz Perales, president of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU), participated on Wednesday in the event “Health Governance and Public-Private Partnerships: The Value of Women’s Leadership, ” organized by CESIF, a business school specializing in the biopharmaceutical industry.
The event, held as part of “Women’s Month,” brought together institutional representatives and leaders from the healthcare and pharmaceutical sectors to discussthe role of women’s leadership in strategic decision-makingand the evolution of the healthcare governance model.
The opening remarks were delivered byEva Serrano, vice president of the Madrid Chamber of Commerce. She was followed by the president of AELMHU, who provided the keynote address for the event.
“El liderazgo femenino no es solo una cuestión de igualdad, sino una oportunidad para mejorar la calidad de las decisiones en salud y reforzar las capacidades de nuestro sistema sanitario”, ha señalado Beatriz Perales.
En su intervención, ha destacado tres ideas clave. La primera, centrada en el liderazgo femenino como palanca de valor: “Si queremos un sistema sanitario más innovador, más sostenible y más preparado para el futuro, no podemos permitirnos prescindir del talento que aportamos las mujeres”.
Además, ha defendido la importancia de la diversidad y de la colaboración, junto con estilos de liderazgo que sean “capaces de generar confianza”. “Así como construir puentes entre organizaciones y de promover espacios de colaboración público-privada para afrontar los grandes retos a los que se enfrenta el Sistema Nacional de Salud (SNS)”.
Por último, ha puesto en valor el talento femenino y la oportunidad de formar a las líderes del futuro: “Es fundamental promover entornos que favorezcan el desarrollo profesional, visibilicen referentes femeninos y sitúen la diversidad como un activo estratégico de las organizaciones“.
Following Beatriz Perales’s opening remarks, the event continued with a roundtable discussion moderated by Jorge Vázquez, partner and director of the Healthcare Practice at VINCES and national representative for Industry on the General Council of Official Colleges of Pharmacists. Participants included Pilar Jimeno, director general of Health Inspection and Planning for the Community of Madrid; Elena Casaus, Secretary General of the Spanish Association of Generic Medicines (AESEG); Marta Villanueva, Director General of the IDIS Foundation; Raquel Martínez, Secretary General of the General Council of Official Colleges of Pharmacists and Vice President of the International Pharmaceutical Federation; and Nuria González, Director of the Healthcare Innovative Solution Unit at Novartis. The event concluded with remarks byRaquel Yotti, PERTE Commissioner for Cutting-Edge Health, and closing remarks by Clara Campos, CEO of CESIF.
